🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/07/2009 10,38 10,50 10,20 10,50 +1,16% 2,89% 99.950
22/07/2009 10,20 10,38 9,66 10,38 +2,98% 7,06% 103.567
21/07/2009 10,20 10,20 9,78 10,08 +0,00% 4,12% 90.700
20/07/2009 10,32 10,68 10,02 10,08 -1,75% 6,40% 151.267
17/07/2009 9,60 10,50 9,48 10,26 +7,55% 10,63% 130.800
16/07/2009 9,06 9,54 9,06 9,54 +3,25% 5,30% 50.483
15/07/2009 9,42 9,54 9,06 9,24 -0,65% 5,10% 98.033
14/07/2009 8,16 9,72 8,10 9,30 +14,81% 19,85% 160.817
13/07/2009 7,98 8,10 7,44 8,10 +2,27% 8,27% 59.100
10/07/2009 7,50 7,98 7,38 7,92 +5,60% 8,00% 49.267
09/07/2009 7,98 7,98 7,38 7,50 -2,34% 7,52% 112.667
08/07/2009 9,24 9,24 7,20 7,68 -16,88% 22,08% 319.433
07/07/2009 9,54 9,66 9,18 9,24 -3,14% 5,03% 73.883
06/07/2009 9,36 10,14 9,00 9,54 +1,92% 12,18% 122.683
02/07/2009 9,54 9,60 9,30 9,36 -2,50% 3,14% 131.883
01/07/2009 9,54 9,96 9,54 9,60 +1,27% 4,40% 94.500
30/06/2009 10,02 10,08 9,48 9,48 -5,95% 5,99% 164.400
29/06/2009 9,36 10,80 9,36 10,08 -10,16% 15,38% 440.550
26/06/2009 9,90 11,88 9,36 11,22 +14,02% 25,45% 2.022.250
25/06/2009 9,00 9,90 8,82 9,84 +9,33% 12,00% 143.667
24/06/2009 9,12 9,24 8,82 9,00 +2,04% 4,61% 99.933
23/06/2009 9,54 9,54 8,46 8,82 -3,92% 11,32% 121.117
22/06/2009 10,20 10,38 8,88 9,18 +0,00% 14,71% 342.733
19/06/2009 9,00 10,14 8,94 9,18 +4,08% 13,33% 225.167
18/06/2009 8,28 8,82 8,16 8,82 +5,76% 7,97% 79.550
17/06/2009 8,04 8,34 7,86 8,34 +0,72% 5,97% 62.350
16/06/2009 8,04 8,58 7,98 8,28 +0,73% 7,46% 96.300
15/06/2009 8,70 8,88 8,04 8,22 -8,05% 9,66% 102.783
12/06/2009 9,30 9,30 8,52 8,94 -3,25% 8,39% 65.833
11/06/2009 9,18 9,36 8,52 9,24 +2,67% 9,15% 138.750